Dual targeting of human epidermal growth factor receptor 2 (HER2) in neoadjuvant trials for operable HER2 positive (HER2+) disease Article
Overview
publication date
- November 15, 2013
published in
- Current Breast Cancer Reports Journal
Identity
Scopus Document Identifier
- 84891872430
Digital Object Identifier (DOI)
- 10.1007/s12609-013-0124-x
Additional Document Info
volume
- 5
issue
- 4